Abstract
This article reviews developments related to the use of plant sterols and stanols as cholesterol-lowering ingredients in foods and nutraceuticals preparations. Plant sterols and stanols are extracted from the deodorizer distillates of vegetable oil refining and from tall oil, a by-product of paper pulping industry. Plant sterols/stanols inhibit cholesterol absorption possibly by competitively inhibiting its incorporation into the mixed micelles in the small intestine although other mechanisms can not be excluded. Daily consumption of 1-2 grams of plant sterols or stanols was shown to cause 10- 20% reduction in low-density lipoprotein cholesterol (LDL cholesterol). Combinations of plant sterols/stanols with certain lipid-lowering ingredients were shown to potentate their cholesterol-lowering effects and, in some cases, add triacylglycerol-lowering effects. In this article, patents based information is also discussed.
Keywords: Plant sterols, plant stanols, cholesterol-lowering, health-promoting effects, functional foods
Recent Patents on Food, Nutrition & Agriculture
Title: Plant Sterols and Stanols as Cholesterol-Lowering Ingredients in Functional Foods
Volume: 1 Issue: 1
Author(s): Afaf Kamal-Eldin and Ali Moazzami
Affiliation:
- Department of Food Science,Swedish University of Agricultural Sciences (SLU), Box 7051, 750 07 Uppsala, Sweden,Sweden
Keywords: Plant sterols, plant stanols, cholesterol-lowering, health-promoting effects, functional foods
Abstract: This article reviews developments related to the use of plant sterols and stanols as cholesterol-lowering ingredients in foods and nutraceuticals preparations. Plant sterols and stanols are extracted from the deodorizer distillates of vegetable oil refining and from tall oil, a by-product of paper pulping industry. Plant sterols/stanols inhibit cholesterol absorption possibly by competitively inhibiting its incorporation into the mixed micelles in the small intestine although other mechanisms can not be excluded. Daily consumption of 1-2 grams of plant sterols or stanols was shown to cause 10- 20% reduction in low-density lipoprotein cholesterol (LDL cholesterol). Combinations of plant sterols/stanols with certain lipid-lowering ingredients were shown to potentate their cholesterol-lowering effects and, in some cases, add triacylglycerol-lowering effects. In this article, patents based information is also discussed.
Export Options
About this article
Cite this article as:
Kamal-Eldin Afaf and Moazzami Ali, Plant Sterols and Stanols as Cholesterol-Lowering Ingredients in Functional Foods, Recent Patents on Food, Nutrition & Agriculture 2009; 1(1) . https://dx.doi.org/10.2174/2212798410901010001
| DOI https://dx.doi.org/10.2174/2212798410901010001 |
Print ISSN 2212-7984 |
| Publisher Name Bentham Science Publisher |
Online ISSN 1876-1429 |
Related Articles
-
Vitamin D Intervention Trials in Critical Illness
Inflammation & Allergy - Drug Targets (Discontinued) Editorial: The Interplay between TSH and Lipids. What Should Clinicians Know?
Current Vascular Pharmacology Deep Inspiration Breath-hold (DIBH) Technique to Reduce Cardiac Radiation Dose in the Management of Breast Cancer
Current Cancer Therapy Reviews Parkinsons Disease: Genetics and Beyond
Current Neuropharmacology Potential Targets for Intervention in Radiation-Induced Heart Disease
Current Drug Targets Targeted Drugs and Nanomedicine: Present and Future
Current Pharmaceutical Design The Role of Mediterranean Diet, CoQ10 and Conjugated-Melatonin in Osteoporosis Primary Prevention and Therapy
Current Nutrition & Food Science Editorial [Hot Topic : Current Practice and trends in echocardiography in Critical Care, Anesthesiology and Emergency Medicine (Guest Editor: Paulo Marcelino)]
Current Cardiology Reviews Therapeutic Implications of Immune-endocrine Interactions in the Critically Ill Patients
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Do We Need More Research on Platelet Function in South Asian Immigrants?
Inflammation & Allergy - Drug Targets (Discontinued) Therapeutic Agents Against COVID-19 with Clinical Evidence
Current Pharmaceutical Design Synergistic Two-Way Interactions of Dietary Polyphenols and Dietary Components on the Gut Microbial Composition: Is There a Positive, Negative, or Neutralizing Effect in the Prevention and Management of Metabolic Diseases?
Current Protein & Peptide Science Therapy Of Cardiac Arrhythmias In Children: An Emerging Role Of Electroanatomical Mapping Systems
Current Vascular Pharmacology Drug Discovery and Design for Complex Diseases through QSAR Computational Methods
Current Pharmaceutical Design Research on the Pathological Mechanism and Drug Treatment Mechanism of Depression
Current Neuropharmacology The Effects of Antihypertensive Therapy on Haemostatic Parameters
Current Pharmaceutical Design Application of Nanomedicine in Cardiovascular Diseases and Stroke
Current Pharmaceutical Design The Role of Inflammation in Epicardial Adipose Tissue in Heart Diseases
Current Pharmaceutical Design Advanced Glycation End Products (AGEs) and Cardiovascular Disease (CVD) in Diabetes
Cardiovascular & Hematological Agents in Medicinal Chemistry Vitamins B1, B2, B3 and B9 – Occurrence, Biosynthesis Pathways and Functions in Human Nutrition
Mini-Reviews in Medicinal Chemistry

